STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Company

Cartesian Therapeutics, Inc.

Filed

October 15, 2024

Period of Report

October 11, 2024

Accession Number

0001062993-24-017675